Is albumin a blood component or a blood product?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Albumin Classification: Blood Product vs. Blood Component

Albumin is a blood product, not a blood component. It is a human-derived, processed plasma protein that undergoes purification and manufacturing steps, distinguishing it from direct blood components like packed red blood cells or fresh frozen plasma 1, 2.

Key Distinctions

Blood Product Characteristics of Albumin

  • Manufactured from human plasma: Albumin is obtained through separation and purification of human plasma, requiring extensive processing beyond simple component separation 3, 4
  • Available in standardized concentrations: Commercially prepared as 5%, 20%, or 25% solutions, which requires industrial manufacturing processes 1, 2
  • Heat-treated and virus-inactivated: Unlike direct blood components, albumin undergoes sterilization procedures that eliminate hepatitis virus transmission risk 5
  • Stable for prolonged storage: Can be stored at variable temperatures and sterilized by autoclaving, unlike labile blood components 5

Why It's Not a Blood Component

  • Blood components (packed RBCs, platelets, fresh frozen plasma, cryoprecipitate) are separated directly from whole blood through centrifugation without chemical modification 1
  • Blood products like albumin undergo additional manufacturing, purification, and concentration steps beyond simple physical separation 3, 4

Clinical Implications

Transfusion Medicine Context

  • Guidelines distinguish between "blood products" and "blood components" when discussing transfusion protocols 1
  • Routine measurement of prothrombin time and platelet count before paracentesis with infusion of blood products (referring to albumin) is not recommended, using terminology that separates albumin from direct blood components 1

Regulatory and Cost Considerations

  • Albumin is expensive (approximately $130 per 25g) and accounts for up to 30% of pharmacy budgets in some hospitals, reflecting its status as a manufactured pharmaceutical product rather than a simple blood component 2, 3
  • The manufacturing process ensures constant composition and freedom from infectious agents, characteristics of processed blood products 5, 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Albumin Transfusions: Clinical Applications and Evidence

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Albumin therapy in clinical practice.

Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition, 2005

Research

Overview of Albumin and Its Purification Methods.

Advanced pharmaceutical bulletin, 2016

Research

Blood substitutes.

Canadian Anaesthetists' Society journal, 1975

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.